Performance and Safety of the Innofix® Screw (IF25)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInnoprod Medical

About this trial

The purpose of this clinical investigation is to collect data about the safety and the performances of the InnoFix® screw : Clinical performances (Pain reduction due to the fracture treatment, maintenance of the stabilizaton of the treated fracture and mobility improvement) / Technical performances (Percutaneous implantation by mini-invasive approach, Efficiency of percutaneous implementation and efficiency of percuatneous cementing) / Safety performances (Preservation of the screw stability after implantation and preservation of the screw integrity after implantation). The safety and performance data about the InnoFix® screw will be used to obtain their CE marking according to the regulation (EU) 2017/745.

The principal objective of this clinical investigation is to assess the postoperative reduction in pain level of the patient at 6 weeks follow-up.

Eligibility criteria

Qualifiers

The patient is 18 years old or more

The patient is a cancer patient

The patient needs a stabilization of a non-displaced pathologic fracture (complete or impending) of the pelvic bone

The patient is symptomatic with musculoskeletal pain exacerbated during movement or weight bearing

Disqualifiers

The patient has got a displaced fracture or an unstable fracture justifying conventional surgical fixation

The patient is a pregnant woman or considered getting pregnant during its investigation participation

The patient presents medical conditions that could have an impact on the clinical investigation (under responsibility of the investigator)

The patient has got one or more contraindications to general anaesthesia

Trial design

Treatments tested in this trial

  • Percutaneous fixation by internal cemented screw (InnoFix®)

Treatment groups

34 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators